$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

$cpix Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000162828018003034 Filed on March 09, 2018

Income Statement

Concept	2016 Q4	2016 Q3	2016 Q2
Revenue	$9.081M	$8.792M	$7.415M
YoY Change	12.99%	11.5%	-16.78%
Cost Of Revenue	$1.610M	$1.974M	$1.155M
YoY Change	1.26%	101.39%	-6.61%
Gross Profit	$7.480M	$6.818M	$6.260M
YoY Change	15.97%	-1.26%	-18.42%
Gross Profit Margin	82.37%	77.55%	84.42%
Selling, General & Admin	$6.710M	$5.480M	$5.147M
YoY Change	24.95%	1.43%	-9.05%
% of Gross Profit	89.71%	80.38%	82.22%
Research & Development	$1.160M	$644.7K	$678.8K
YoY Change	190.0%	-14.89%	-18.03%
% of Gross Profit	15.51%	9.46%	10.84%
Depreciation & Amortization	$610.0K	$620.0K	$590.0K
YoY Change	7.02%	14.81%	1.72%
% of Gross Profit	8.16%	9.09%	9.43%
Operating Expenses	$8.430M	$6.125M	$5.825M
YoY Change	34.24%	-0.58%	-10.2%
Operating Profit	-$957.4K	$130.1K	-$105.3K
YoY Change	-688.5%	-51.96%	-115.63%
Interest Expense	$20.00K	$29.09K	$28.25K
YoY Change	100.0%	46.8%	52.78%
% of Operating Profit		22.35%
Other Income/Expense, Net
YoY Change
Pretax Income	-$940.0K	$152.7K	-$102.1K
YoY Change	-652.94%	-51.55%	-114.31%
Income Tax	-$170.0K	$57.19K	-$41.14K
% Of Pretax Income		37.46%
Net Earnings	-$749.7K	$106.2K	-$48.04K
YoY Change	-596.29%	-16.15%	-111.79%
Net Earnings / Revenue	-8.26%	1.21%	-0.65%
Basic Earnings Per Share	-$0.05	$0.01	$0.00
Diluted Earnings Per Share	-$0.05	$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	16.18M shares	16.22M shares	16.25M shares
Diluted Shares Outstanding		16.50M shares	16.25M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.13M	$50.15M	$50.40M
YoY Change	-4.99%	-4.94%	-5.04%
Cash & Equivalents	$34.51M	$35.55M	$35.84M
Short-Term Investments	$15.62M	$14.60M	$14.57M
Other Short-Term Assets	$2.711M	$5.161M	$4.117M
YoY Change	-32.19%	3.99%	-8.91%
Inventory	$5.372M	$4.983M	$4.922M
Prepaid Expenses
Receivables	$7.330M	$6.672M	$4.551M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$65.55M	$66.96M	$63.99M
YoY Change	1.49%	-1.12%	-6.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$464.5K	$482.6K	$505.7K
YoY Change	-13.42%	-10.92%	-11.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.121M	$2.456M	$2.510M
YoY Change	12.15%	-4.53%	5.15%
Total Long-Term Assets	$27.86M	$24.11M	$23.90M
YoY Change	1.92%	-0.93%	-3.31%
TOTAL ASSETS
Total Short-Term Assets	$65.55M	$66.96M	$63.99M
Total Long-Term Assets	$27.86M	$24.11M	$23.90M
Total Assets	$93.40M	$91.07M	$87.89M
YoY Change	1.62%	-1.07%	-5.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.037M	$6.658M	$3.667M
YoY Change	179.29%	61.34%	-10.77%
Accrued Expenses	$6.756M
YoY Change	-29.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.79M	$11.69M	$8.895M
YoY Change	19.18%	-1.59%	-22.97%
LONG-TERM LIABILITIES
Long-Term Debt	$4.100M	$3.700M	$3.500M
YoY Change	141.18%	117.65%	105.88%
Other Long-Term Liabilities	$1.391M	$1.300M	$1.100M
YoY Change	40.92%	44.44%	10.0%
Total Long-Term Liabilities	$1.391M	$5.000M	$4.600M
YoY Change	40.92%	92.31%	70.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.79M	$11.69M	$8.895M
Total Long-Term Liabilities	$1.391M	$5.000M	$4.600M
Total Liabilities	$20.28M	$16.65M	$13.51M
YoY Change	34.34%	14.72%	-4.93%
SHAREHOLDERS EQUITY
Retained Earnings	$18.60M	$19.35M	$19.25M
YoY Change	-4.83%	-0.23%	-0.11%
Common Stock	$54.64M	$55.18M	$55.22M
YoY Change	-4.7%	-5.18%	-7.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$73.25M	$74.53M	$74.47M
YoY Change
Total Liabilities & Shareholders Equity	$93.40M	$91.07M	$87.89M
YoY Change	1.62%	-1.07%	-5.41%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2016 Q2
OPERATING ACTIVITIES
Net Income	-$749.7K	$106.2K	-$48.04K
YoY Change	-596.29%	-16.15%	-111.79%
Depreciation, Depletion And Amortization	$610.0K	$620.0K	$590.0K
YoY Change	7.02%	14.81%	1.72%
Cash From Operating Activities	$820.0K	$290.0K	-$1.140M
YoY Change	-38.35%	-39.58%	-155.88%
INVESTING ACTIVITIES
Capital Expenditures	-$480.0K	-$500.0K	-$450.0K
YoY Change	128.57%	-261.29%	-28.57%
Acquisitions
YoY Change
Other Investing Activities	-$1.010M	-$20.00K	$310.0K
YoY Change	676.92%	-92.59%	-224.0%
Cash From Investing Activities	-$1.500M	-$520.0K	-$150.0K
YoY Change	354.55%	-1400.0%	-82.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-360.0K	-70.00K	690.0K
YoY Change	-66.97%	-93.97%	-154.76%
NET CHANGE
Cash From Operating Activities	820.0K	290.0K	-1.140M
Cash From Investing Activities	-1.500M	-520.0K	-150.0K
Cash From Financing Activities	-360.0K	-70.00K	690.0K
Net Change In Cash	-1.040M	-300.0K	-600.0K
YoY Change	1055.56%	-53.12%	500.0%
FREE CASH FLOW
Cash From Operating Activities	$820.0K	$290.0K	-$1.140M
Capital Expenditures	-$480.0K	-$500.0K	-$450.0K
Free Cash Flow	$1.300M	$790.0K	-$690.0K
YoY Change	-15.58%	364.71%	-125.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	319228	USD
CY2017Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	1055220	USD
CY2016Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	990000	USD
CY2017Q4	cpix	Accrued Liabilities Stock Payable AccruedLiabilitiesStockPayable	1324800	USD
CY2015	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	0	USD
CY2016	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	0	USD
CY2017	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	97254	USD
CY2016Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	738541	USD
CY2017Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	624367	USD
CY2016Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	3881415	USD
CY2017Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	15295547	USD
CY2016Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	331301	USD
CY2017Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	232667	USD
CY2016Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	771034	USD
CY2017Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	538141	USD
CY2017	cpix	Defined Contribution Plan Eligibility Minimum Employee Age DefinedContributionPlanEligibilityMinimumEmployeeAge	P21Y
CY2017	cpix	Defined Contribution Plan Eligibility Minimum Employee Service Time For Participation Eligibility DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility	P6M
CY2015	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	257545	USD
CY2016	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	202868	USD
CY2017	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	211532	USD
CY2015	cpix	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0.00
CY2016	cpix	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0.00
CY2017	cpix	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017Percent	0.02
CY2017Q4	cpix	Finite Lived Intangible Assets Amortization Expense Year Fiveand After FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter	11303197	USD
CY2014Q2	cpix	Loans Forgivenin Exchange For Share Issued Amount LoansForgiveninExchangeForShareIssuedAmount	2400000	USD
CY2016Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	3508430	USD
CY2017Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	15719445	USD
CY2017Q4	cpix	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	916477	USD
CY2016Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	4051029	USD
CY2017Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	4683694	USD
CY2015	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	967146	USD
CY2016	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-1179394	USD
CY2017	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-513481	USD
CY2017	cpix	Revenue Recognition Cumulative Upfront Payment RevenueRecognitionCumulativeUpfrontPayment	1500000	USD
CY2017	cpix	Revenue Recognition Potential Upfront Payment Relatedto Product Sales RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales	4600000	USD
CY2017	cpix	Revenue Recognition Potential Upfront Payments Relatedto Regulatory Approval RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval	2400000	USD
CY2017	cpix	Revenue Recognition Relatedto Milestone Payments RevenueRecognitionRelatedtoMilestonePayments	100000	USD
CY2017	cpix	Revenue Recognition Upfront Payment RevenueRecognitionUpfrontPayment	1500000	USD
CY2017	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	3	plan
CY2017	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Available For Future Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants	2	plan
CY2015	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	3.26
CY2017	cpix	Sharebased Compensation Charitable Contributionof Shares SharebasedCompensationCharitableContributionofShares	372500	USD
CY2015	cpix	Sharebased Compensation Foundation Contribution SharebasedCompensationFoundationContribution	0	USD
CY2016	cpix	Sharebased Compensation Foundation Contribution SharebasedCompensationFoundationContribution	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38203059	USD
CY2016	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0.00
CY2017	cpix	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0.00
CY2017	cpix	Sharebased Compensation Foundation Contribution SharebasedCompensationFoundationContribution	372500	USD
CY2017	cpix	Tax Cutsand Jobs Actof2017 Changein Tax Rate Deferred Tax Asset Income Tax Expense Benefit TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxAssetIncomeTaxExpenseBenefit	4867893	USD
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001087294
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15652356	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	66029460	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	CUMBERLAND PHARMACEUTICALS INC
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8036611	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8979929	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7330127	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8395112	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6755652	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8714814	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2699940	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2911472	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	2576070	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	2626238	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	2589185	USD
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46422	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	84539	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	77911	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1989264	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2194039	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2436222	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	46633	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13300	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18325	shares
CY2016Q4	us-gaap	Assets Assets	93404566	USD
CY2017Q4	us-gaap	Assets Assets	93232312	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	65545264	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	68684845	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39866037	USD
CY2016Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2017Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34510330	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45412868	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1662978	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3692729	USD
CY2016	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	619580	USD
CY2017	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	4115646	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	104504	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10902538	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16074176	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15723075	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16074176	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15723075	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	54643268	USD
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	52410941	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	671108	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1003938	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8049815	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	731351	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-944683	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7978633	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4968170	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5958660	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	7370585	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	32407441	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	34458691	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	45231479	USD
CY2016Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1082924	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	41326	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-867041	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	85602	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-950504	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	59243	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	44276	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-83463	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	59243	USD
CY2016Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	1200000	USD
CY2017Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	1600000	USD
CY2016Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1900000	USD
CY2017Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	2300000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	385723	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	537965	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3682772	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	490227	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	619580	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4206753	USD
CY2015	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	490227	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	81615	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17786993	USD
CY2016Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	214654	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	432874	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6746941	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	173885	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3119930	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	87210	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	3119930	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	87210	USD
CY2017Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	639263	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	793206	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	170733	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	129180	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	388500	USD
CY2017Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15900000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15632235	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3238511	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2067548	USD
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2246809	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2396908	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2647753	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.46
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.08
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.03
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.15
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1.48
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.07
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.02
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.01
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.02
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.03
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.05
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.01
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	872914	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1032652	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2100000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	90982	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-1026413	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	90982	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-1026413	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	91109	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2519024	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2465544	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2614010	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2542770	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22154176	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21444545	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7607588	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8561811	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10030370	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1246937	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1334862	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3874926	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	575829	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-330924	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4174889	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	52238	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-8359	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2307617	USD
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2731	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	386863	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	413097	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	263084	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	18000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1475964	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	191901	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	572392	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1253007	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1064985	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1330176	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1101586	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1366118	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1556282	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1074369	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	378784	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015	us-gaap	Interest Expense InterestExpense	73856	USD
CY2016	us-gaap	Interest Expense InterestExpense	106392	USD
CY2017	us-gaap	Interest Expense InterestExpense	92904	USD
CY2015	us-gaap	Interest Paid InterestPaid	27434	USD
CY2016	us-gaap	Interest Paid InterestPaid	21853	USD
CY2017	us-gaap	Interest Paid InterestPaid	14993	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2283694	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3331882	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	5371729	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	6737848	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2810711	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3156002	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	300000	USD
CY2017Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	200000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	209183	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	204661	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	299326	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	978591	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1150614	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1074437	USD
CY2016Q4	us-gaap	Liabilities Liabilities	20283747	USD
CY2017Q4	us-gaap	Liabilities Liabilities	29310711	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	93404566	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	93232312	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14792263	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17694743	USD
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	4100000	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	9800000	USD
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	15622111	USD
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4672476	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	-127380	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	-198562	USD
CY2014Q1	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.85
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5194871	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1147128	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1947675	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2344972	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3115079	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9512577	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5876865	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	569478	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-557714	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	731351	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-253111	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-48044	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	106166	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-749694	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-944683	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-1274446	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-5160611	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-743031	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-800545	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-7978633	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-60243	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-59255	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-71182	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1000005	USD
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	1111610	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-500583	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-105309	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	130132	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-957371	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-1433131	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-657802	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1680871	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-839349	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-903326	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-4081348	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4839359	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	980657	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	600000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1001603	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	980720	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	959902	USD
CY2015	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	550452	USD
CY2016	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	646235	USD
CY2017	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	573494	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2120742	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2486830	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-60243	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-59255	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-71182	USD
CY2016Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	277324	USD
CY2017Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	249964	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	522481	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	618448	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1391484	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1815968	USD
CY2015	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	77155	USD
CY2016	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	74015	USD
CY2017	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	52012	USD
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	505867	USD
CY2016	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	547375	USD
CY2017	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	773568	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5338967	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2520715	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3724375	USD
CY2015	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1668252	USD
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2015	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	27950	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2556465	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2000226	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1213110	USD
CY2014Q2	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1000000	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7528713	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5473092	USD
CY2017	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2379414	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	142965	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	130872	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	275960	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2710967	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3466541	USD
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1700000	USD
CY2016	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2400000	USD
CY2017	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	24500000	USD
CY2015	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	7883171	USD
CY2016	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4489111	USD
CY2017	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	13381061	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	21366	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015	us-gaap	Profit Loss ProfitLoss	671108	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-1003938	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-8049815	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3164394	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3440354	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	464454	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	528882	USD
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	18800000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3847651	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3190700	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3901365	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	18604931	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11709222	USD
CY2015	us-gaap	Revenues Revenues	900000	USD
CY2016	us-gaap	Revenues Revenues	2000000	USD
CY2017	us-gaap	Revenues Revenues	1600000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	33013184	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	32478185	USD
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	40376563	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	33519051	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	7737532	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	7414835	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	8791753	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	9081440	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	33025560	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	9636755	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	8667127	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	11196961	USD
CY2017Q4	us-gaap	Sales Revenue Net SalesRevenueNet	11649288	USD
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	41150131	USD
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13994768	USD
CY2016	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14553481	USD
CY2017	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21492937	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	622503	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	852102	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1115063	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5800	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	13.00
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	6500	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.00
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2320	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3875	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12300	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5800	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5800	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.89
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.00
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.00
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y10M15D
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y7M15D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M15D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M15D
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	839450	USD
CY2016	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	703353	USD
CY2017	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	621142	USD
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	622503	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	852102	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1115063	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	112348	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-1026413	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5338967	USD
CY2016	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2520715	USD
CY2017	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3719890	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	73248199	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	64120163	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	80752791	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	76819783	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	73120819	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63921601	USD
CY2016Q4	us-gaap	Trading Securities TradingSecurities	15622111	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	4672476	USD
CY2017	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	4202854	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17094754	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16236525	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15911577	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16715970	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16236525	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15911577	shares
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-left:4px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;padding-left:24px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-18-003034-index-headers.html	Edgar Link	pending
0001628280-18-003034-index.html	Edgar Link	pending
0001628280-18-003034.txt	Edgar Link	pending
0001628280-18-003034-xbrl.zip	Edgar Link	pending
a2017-10k.htm	Edgar Link	pending
a2017-10kxexhibit1011ajkaz.htm	Edgar Link	pending
a2017-10kxexhibit1012marti.htm	Edgar Link	pending
a2017-10kxexhibit1013leopa.htm	Edgar Link	pending
a2017-10kxexhibit1014micha.htm	Edgar Link	pending
a2017-10kxexhibit1015jimhe.htm	Edgar Link	pending
a2017-10kxexhibit231consen.htm	Edgar Link	pending
a2017-10kxexhibit232consen.htm	Edgar Link	pending
a2017-10kxexhibit311.htm	Edgar Link	pending
a2017-10kxexhibit312.htm	Edgar Link	pending
a2017-10kxexhibit321.htm	Edgar Link	pending
chart-23fc7453f71651b49b5.jpg	Edgar Link	pending
cpix-20171231.xml	Edgar Link	completed
cpix-20171231.xsd	Edgar Link	pending
cpix-20171231_cal.xml	Edgar Link	unprocessable
cpix-20171231_def.xml	Edgar Link	unprocessable
cpix-20171231_lab.xml	Edgar Link	unprocessable
cpix-20171231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2016 Q4 Form 10-K Financial Statement

#000162828018003034 Filed on March 09, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2016 Q4 Form 10-K Financial Statement

#000162828018003034 Filed on March 09, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix